Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Alnylam Pharmaceuticals (ALNY)

Alnylam Pharmaceuticals (ALNY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Alnylam (ALNY) Moves to Buy: Rationale Behind the Upgrade

Alnylam (ALNY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

ALNY : 117.74 (-2.38%)
Here's Why Momentum Investors Will Love Alnylam Pharmaceuticals (ALNY)

Does Alnylam Pharmaceuticals (ALNY) have what it takes to be a top stock pick for momentum investors? Let's find out.

ALNY : 117.74 (-2.38%)
Guest Host Tonight

Guest Host Tonight

ALNY : 117.74 (-2.38%)
Uptrend Call Working As Alnylam Pharmace Stock Rises 44.6% (ALNY)

SmarTrend identified an Uptrend for Alnylam Pharmace (NASDAQ:ALNY) on October 21st, 2019 at $85.25. In approximately 2 months, Alnylam Pharmace has returned 44.63% as of today's recent price of $123.30....

ALNY : 117.74 (-2.38%)
Trade of the 2020's: Sell Gold, Buy Biotech

In 5 years, you be selling your gold and buying more companies leading the century of biology.

IBB : 120.63 (+0.28%)
ALNY : 117.74 (-2.38%)
NVDA : 223.99 (-0.04%)
CME : 204.59 (+0.71%)
CRSP : 65.36 (-1.01%)
SmarTrend Watching for Potential Pullback in Shares of Alnylam Pharmace After 2.97% Gain

Alnylam Pharmace (NASDAQ:ALNY) traded in a range yesterday that spanned from a low of $119.90 to a high of $122.40. Yesterday, the shares gained 3.0%, which took the trading range above the 3-day high...

ALNY : 117.74 (-2.38%)
The Zacks Analyst Blog Highlights: GLD, CRSP, GBT, ALNY and ARKG

The Zacks Analyst Blog Highlights: GLD, CRSP, GBT, ALNY and ARKG

GLD : 139.05 (+0.45%)
ALNY : 117.74 (-2.38%)
GBT : 76.88 (-0.01%)
CRSP : 65.36 (-1.01%)
ARKG : 34.54 (+0.09%)
Alnylam Gets Second Product Approval Amid Stiff Competition

Alnylam (ALNY) gets FDA approval for givosiran injection for subcutaneous use to treat adults with acute hepatic porphyria. Givosiran injection will be marketed by the trade name of Givlaari.

SNY : 49.79 (+0.57%)
ALNY : 117.74 (-2.38%)
MDCO : 84.22 (+0.23%)
REGN : 376.42 (+1.14%)
Why Gold is Headed to Zero -- And What You Should Buy Instead

Why Gold is Headed to Zero -- And What You Should Buy Instead

TSLA : 358.39 (-0.36%)
IBB : 120.63 (+0.28%)
GLD : 139.05 (+0.45%)
GBT : 76.88 (-0.01%)
CRSP : 65.36 (-1.01%)
ARKG : 34.54 (+0.09%)
ALNY : 117.74 (-2.38%)
Alnylam Pharmaceuticals, Inc. (ALNY) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Alnylam Pharmaceuticals, Inc. (ALNY).

ALNY : 117.74 (-2.38%)
Alnylam to Webcast Presentations at Upcoming December Investor Conferences

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present company overviews at the following conferences:

ALNY : 117.74 (-2.38%)
Alnylam Pharmace Has Returned 31.2% Since SmarTrend Recommendation (ALNY)

SmarTrend identified an Uptrend for Alnylam Pharmace (NASDAQ:ALNY) on October 21st, 2019 at $85.25. In approximately 1 month, Alnylam Pharmace has returned 31.24% as of today's recent price of $111.88....

ALNY : 117.74 (-2.38%)
Alnylam Pharmace Set to Possibly Pullback After Yesterday's Rally of 4.65%

Alnylam Pharmace (NASDAQ:ALNY) traded in a range yesterday that spanned from a low of $110.74 to a high of $116.50. Yesterday, the shares gained 4.6%, which took the trading range above the 3-day high...

ALNY : 117.74 (-2.38%)
The Medicines Company to be Acquired by Novartis for $9.7B

The Medicines Company (MDCO) agrees to the $85 per share or $9.7-billion acquisition offer from Novartis.

NVS : 92.99 (-0.08%)
MDCO : 84.22 (+0.23%)
ALNY : 117.74 (-2.38%)
AMGN : 236.74 (+0.32%)
Alnylam Announces 2020 Product and Pipeline Goals and Provides Updates at R&D Day

--- Initiates HELIOS-B Phase 3 Study of Investigational Vutrisiran in ATTR Amyloidosis Cardiomyopathy -

ALNY : 117.74 (-2.38%)
Alnylam's Givosiran Gets FDA Nod for Acute Hepatic Porphyria

Alnylam (ALNY) gets FDA approval for givosiran injection, to be marketed by the trade name of Givlaari, for the treatment of adults with AHP.

MDCO : 84.22 (+0.23%)
ANIK : 53.15 (-0.65%)
ALNY : 117.74 (-2.38%)
ALKS : 20.87 (-1.79%)
Alnylam (ALNY) Catches Eye: Stock Jumps 10.5%

Alnylam (ALNY) saw a big move last session, as its shares jumped nearly 11% on the day, amid huge volumes.

ALKS : 20.87 (-1.79%)
ALNY : 117.74 (-2.38%)
Alnylam Announces New and Enhanced Framework for Value-Based Agreements to Accelerate Patient and Provider Access to GIVLAARI(TM) (givosiran)

--a^' Includes New Approach Designed for Ultra-Rare Diseases that Gives Participating Payers Greater Financial Certainty if Disease Prevalence is Higher Than Anticipated -

ALNY : 117.74 (-2.38%)
Alnylam Announces Approval of GIVLAARI(TM) (givosiran) by the U.S. Food and Drug Administration (FDA)

--a^' FDA Approval Received in Less Than Four Months after New Drug Application (NDA) Filing Acceptance -

ALNY : 117.74 (-2.38%)
Medicines Company Up on Rumors of Potential Buyout by Novartis

The Medicines Company (MDCO) is rumored to attract acquisition offers after impressive data readouts from three pivotal studies on PCSK9 inhibitor candidate, inclisiran.

MRK : 89.19 (-0.42%)
NVS : 92.99 (-0.08%)
MDCO : 84.22 (+0.23%)
ALNY : 117.74 (-2.38%)

Van Meerten Stock Picks

The 5 Best Large Caps
I wanted to find which Large Caps had the best momentum so I used Barchart to sort the S&P 500 Large Cap Index first by the highest technical buy signals, then by the most frequent number of new highs in the last month.
CCI +0.68 , AIZ -0.29 , SBAC +7.43 , SO +0.05 , WELL -0.46
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar